NCT06171360View on ClinicalTrials.gov

A Study of the Gut Microbiome in Hormone Receptor-positive HER2-negative Breast Cancer Treated With CDK4/6 Inhibitors

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

November 15, 2026

Study Completion Date

December 31, 2030

Conditions
Breast Cancer
Trial Locations (3)

1070

RECRUITING

Institut Jules Bordet, Brussels

1200

RECRUITING

Cliniques universitaires Saint-Luc, Brussels

5000

RECRUITING

CHU UCL Namur, Namur

Sponsors

Collaborators (1)

Jules Bordet Institute
All Listed Sponsors
collaborator

Jules Bordet Institute

OTHER

lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER